Sep 2025

• Conference October 22 - part of Oslo Innovation Week:
  Science Impact 2025 – tomorrow's solutions start today
• PREDI-LYNCH kickoff meeting in Heidelberg:
  Bringing Europe together to tackle Lynch syndrome
• Presentation of KLM’s Career Prize for outstanding research
  Prize winners: Julie Elisabeth Heggelund and Rasmus Iversen
• National Research Archive (NVA) Now Available for OUS Researchers
• Results published in NEJM and The Lancet:
  Beta-blockers reduce risk after heart attack

Aug 2025

• Article from Johanna Olweus's group published in Nature Reviews Cancer
• Radulovic and Stenmark with lysosome review in Nature Reviews Molecular Cell Biology
• August 11-15:
  Oslo University Hospital at Arendalsuka 2025

Jul 2025

• Information for OUS researchers:
  Important Update: Transition from Cristin to the National Research Archive (NVA)

Jun 2025

• Harald Stenmark with ESCRT review in Nature
• Work by Eirik Malinen’s group recognized at the annual PTCOG conference
• Decoding the RNA m6A modification in human early embryonic development
• OUS Researcher Awards 2025 - ceremony June 6th
  Excellent researcher awards to Per Kristian Eide, Ibrahim Akkouh and Mehrdad Rakaee

May 2025

• Ceremony on May 27th
  Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2024
• Press Release:
  PREDI-LYNCH - Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome

Apr 2025

• King Olav V's Prize for Cancer Research 2025 to Karl-Johan Malmberg
• Nasjonalforeningens hjerteforskningspris 2025:
  Heart Research Award to Sigrun Halvorsen

Mar 2025

• Light Meets Precision:
  EIC Pathfinder Project SCALPEL Pioneering a Revolutionary Photoimmunotherapy for Cancer

Feb 2025

• Oslo University Hospital to join the European Federation for Cancer Images (EUCAIM)
• Call from UiO Growth House:
  Seed funding for innovative researchers 2025
• OUH partner in European doctoral network consortium:
  The Mac4Me project is launched
• New atlas over cells in the gut - may contribute to new forms of treatment
• Publication in Nature Communications:
  Preclinical study suggests proteasome inhibitor as therapy for ibrutinib-resistant chronic lymphocytic leukemia

Jan 2025

• The genetic key to bipolar disorder
• Nominate a scientist for the 2025 OUH research awards
  Excellent Researcher Award and Early Career Award
• The HOLOX project funded with 16 mill NOK

Dec 2024

• Announcement: Conference 11-12 February
  Norway Life Science 2025: From Health Data Access to Value and Groundbreaking Research
• Anette Weyergang awarded the Researcher of the Year prize at ICR for 2024
• Norwegian Society for Immunology prize to Stian Foss
• Prestigious ERC Consolidator Grant to Johannes Hov

Nov 2024

• Nature Communications publication:
  A new type of specialized epithelial subtype of cells may hold the key to overcoming resistance to prostate cancer treatments
• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2024
• Announcement from UiO Growth House:
  Innovation Hangout #2 2024 in Oslo Science Park 5 December
• EP PerMed grant awarded to European consortium led by Sigrid S. Skånland at Institute for Cancer Research
• Long term collaboration celebrated:
  Joint meeting in precision medicine between Oslo and Porto scientists
• Journal of Cell Biology publication:
  BEACH domain proteins as new guides in transmembrane cargo sorting
• Groundbreaking Study Identifies Six New Cancer Susceptibility Genes

Oct 2024

• Nobel prize in chemistry to PRIMA collaborator

Sep 2024

• Announcement: UiO Growth House hangout Oct 10
  Innovation hangout for academia and industry
• Infrastructure grant from the Research Council of Norway:
  “ATMP Norway – A National Multimodal Infrastructure for ATMP” awarded 74 MNOK

Aug 2024

• HEV vaccine trial results published in Lancet

Jul 2024

• 70th Anniversary 9-10 September - late registration 5 August
  The Norwegian Cancer Symposium 2024

Jun 2024

• Best Paper Award at the 2024 IEEE International Conference on Communications
  Optimizing Drug Delivery with Advanced Techniques
• Breakthrough in intestinal research:
  Blood test could cut diagnosis time for children and adolcescents with IBD
• OUS Researcher Awards 2024
  Excellent researcher awards to Kjetil Taskén, Chloé B. Steen and Andreas Kleppe
• Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2023

May 2024

• Anita Sveen’s project group publish in Nature Communications
• Findings covered by feature article in national newspaper VG:
  A versatile Fc technology broadly applicable in antibody design aiming for long-acting prophylactic or therapeutic interventions
• Jan Terje Andersen elected as a member of The Norwegian Academy of Science and Letters

Apr 2024

• Heart research award to Kristina Haugaa
• Participants wanted for
  Photo project to portray people with cancer
• Audun Kvalvaag contributes to articles in Science Immunology and Nature Immunology
• New article about effect of nanoparticles on tumors
• Covered by NRK Dagsrevyen:
  Johanna Olweus and her research group first in the Nordics to be on team selected for Cancer Grand Challenges funding

Mar 2024

• Findings from the PATHWAY project presented in feature article in VG:
  Awareness on the connection between childhood trauma and physical pain
• Johanna Olweus interviewed for The Scientist on next-generation cancer therapies
• Mona Guterud honored with Newcomer Award for advancing prehospital stroke treatment

Feb 2024

• Call: UiO Growth House seed funding for innovative researchers 2024
• Discoveries from NoPSC researchers:
  New insight into severe liver disease
• Research awards to the Department of Gastroenterology 
• Collaboration on artificial intelligence:
  Improving lung and breast cancer care through AI-driven precision diagnostics
• Application deadline - May 15th 2024
  New call from National program for clinical therapy research in the specialist health service
• Nature Communications article from Raiborg project group:
  Cancer cells transfer their invasive properties to non-invasive cells
• Publication in Science:
  Treatment-induced resistance mutations in BTK can be overcome by a clinical-stage BTK degrader
• Announcement: nominate a scientist for the 2024 OUH research awards
  Excellent Researcher Award and Early Career Award
• Covered by Dagens Medisin:
  Calling for even more participants for the record-breaking Norwegian Atrial Fibrillation Self-screening Trial (NORSCREEN)

Jan 2024

• Research Funding for Translational Epilepsy Research
• Mother collecting money for supporting precision warfare against cancer cells led by Johanna Olweus

Dec 2023

• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2023
• Sigrid Skånland is awarded Researcher of the Year 2023

Nov 2023

• Dr Ragnar Mørk´s Prize for Excellent Cancer Research 2023 to Mev Dominguez-Valentin

Oct 2023

• Nov. 9, 2023 5:00 PM – 8:00 PM, Oslo Science Park:
  Innovation hangout for academia and industry #3 2023
• New research identifies genetic links between Schizophrenia and Cardiovascular Disease risk factors
• Antiviral drugs could preserve insulin in children newly diagnosed with type 1 diabetes
• Results published in Nature Cancer:
  Possible new treatment for acute myeloid leukemia

Sep 2023

• Kick-off in Oslo September 18-20:
  The Horizon EU Cancer Mission PRIME-ROSE project officially opened
• Licensing validates Norwegian platform technology for the development of tailored monoclonal antibodies
• Johanna Olweus part of research team shortlisted for Cancer Grand Challenges funding
• Team Health Economics at OUH participating at LMI’s Health Economics Seminar
• Sigrun Halvorsen document review coordinator:
  New ESC guidelines for acute coronary syndromes
• OUS-CCC involved in major EU grant to improve cancer infrastructures in Europe
• Innovation conference on 27 September:
  Science Impact 2023 – tomorrow's solutions start today

Aug 2023

• Sigrun Halvorsen interviewed on why the majority of the 100 productive researchers in Norway are men
• First study testing personalized medicine for Inflammatory Bowel Disease
• Kristina Haugaa the second most publishing female researcher in Norway
• Call for Applications:
  NCMM Joint Postdoctoral Program in Molecular Life Science
• Scientists from Institute for Cancer Research with two review articles on lipids

Jul 2023

• Nature Communications article:
  An ATPase mediates autophagosome formation
• Jan Terje Andersen awarded Inven2's "Innovator of the Year" prize for 2023

Jun 2023

• A new technology for mapping m6A in vivo using single cells:
  Papers from Dahl/Klungland groups published in Nature Biotechnology and Nature Structural and Molecular Biology
• New Gemini center established to strengthen research on inflammatory bowel disease (IBD)
• OUS Excellent Articles Awards:
  Prizes for outstanding research articles published in the second half-year of 2022
• Michael Bretthauer wins UEG Research Prize 2023
• OUS Researcher Awards 2023
  Excellent researcher awards to Halvorsen, Kryeziu and Skjerven
• The Pseudovax project presented by Kjersti Flatmark during handover to the Minister of Health
• Hjerteforskningsprisen 2023:
  Prestigious heart research award to Dan Atar
• Tuesday 6 June at 1200-1600:
  Seminar on personalized medicine in infectious diseases and internal medicine

May 2023

• Invitation to seminar - June 20th:
  A dive into the cell – New opportunities for treatment of dementia
• May 24, 2023 8:30 AM–10:00 AM, Oslo Science Park:
  Impact breakfast: Sensors in future healthcare
• Kjetil Taskén is awarded the UiO innovation prize
• The spin-out company Authera from Andersen's group has entered a collaborative agreement with argenx to gain in-depth biologic insights into the complex biology of the neonatal Fc receptor (FcRn)

Apr 2023

• Åslaug Helland receives King Olav V's Prize for Cancer Research 2023
• May 11th 10:00:
  Symposium with ICR SAB member Giulio Superti-Furga
• PRIME-ROSE: EU project receives 6 million EUR from EU Cancer Mission
• Andersen's group contributors to Alzheimer's study published in Science
• Apr. 27, 2023 5:00 PM–8:00 PM, Oslo Science Park:
  Invitation to innovation hangout at UiO
• Findings covered by national television:
  Effects of Non-Compulsory and Mandatory COVID-19 Interventions on Travel Distance and Time Away from Home

Mar 2023

• Åslaug Helland elected as a member of The Norwegian Academy of Science and Letters
• Severe COVID-19 alters LDL, potentially increasing the future risk of cardiovascular disease

Feb 2023

• The Laboratory of Adaptive Immunity and Homeostasis enters a strategic research collaboration with a leading pharmaceutical company
• Covered by Dagens Medisin:
  New research and development project in radiopharmacy granted NOK 15 million by RADFORSK
• Oxford, 30-31 March 2023:
  Colorectal Cancer Research Network Meeting
• Application deadline - May 31st 2023
  New call from National program for clinical therapy research in the specialist health service
• EU SolidAct publishes resuts on Baricitinib as a Treatment for Hospitalized COVID-19 Patients

Jan 2023

• Announcement: nominate a scientist for the 2023 OUH research awards
  Excellent Researcher Award and Early Career Award
• Longitudinal brain age prediction and cognitive function after stroke
• February 16-17 2023 in Oslo:
  National Conference on the Heart and Brain

Dec 2022

• Researcher-of-the-year 2022 at the Institute for Cancer Research:
  Kushtrim Kryeziu
• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2022

Nov 2022

• Pharmacogenomics to improve transplantation oncology of metastatic colorectal cancer
• Ceremony November 25th
  Dr Ragnar Mørk´s Prize for excellent cancer research 2022 to Marina Vietri
• Study led by Aamodt and Atar receive attention:
  Atrial fibrillation the hidden cause of stroke in many patients

Oct 2022

• Invitation to innovation hangout at UiO Nov 10th:
  Topic: Health technology
• Anita Sveen invited speaker at AACR special conference on colorectal cancer

Sep 2022

• New Center of Excellence:
  Integreat - The Norwegian centre for knowledge-driven machine learning
• Horizon Europe 2022 funding to research on personalised treatment with biologic drugs
• Article in "Cancers" receiving international attention:
  Fighting tumors through sugar deprivation

Aug 2022

• Novel findings published in Nature Communications:
  Epigenetic study identifies differential methylation associated with the neuropathology of Parkinson’s disease and dementia with Lewy bodies
• Research uncovers new mechanisms of wound healing:
  Human skin possesses pre-installed mechanisms that guide self-repair

Jun 2022

• Maria Aanesland Dahle winner of the NTNU award for Best Master of Technology 2022
• Innovative Health Initiative launches new calls for proposals
• Service from the University of Oslo Library:
  Digital Scholarship Centre
• Faculty of Medicine, University of Oslo
  Postdoctoral Programme Autumn 2022
• Clinical Trials on Behalf of Industry – New Procedure at OUS
• Award ceremony November 3rd:
  Harald Stenmark awarded Anders Jahre's medical prize for 2022
• OUS Researcher Awards 2022
  Awards for excellent research to Danielsen, Fjellgård Jørgensen and Ringstad
• From the South-Eastern Norway Regional Health Authority:
  Announcement of regional research funding for 2023

May 2022

• Invitation to innovation hangout at UiO 9 June:
  Tomorrow's medicine – advanced therapies, cell therapy, precision medicine and nuclear medicine
• Review article by the Sandvig group:
  Biodistribution, pharmacokinetics and excretion studies of intravenously injected nanoparticles and extracellular vesicles: Possibilities and challenges
• Researchers at OUH are invited to participate in a survey from COAlition S
• Ceremony in the Oslo University Aula May 9th:
  King Olav V´s Cancer Research Award for 2022 to Håvard Danielsen
• Publication in Nature Medicine:
  Norwegian cancer initiatives receive international attention

Apr 2022

• New scoring system to predict long-term mortality after status epilepticus published in JAMA Neurology
• The Nikkilä Memorial Lecture Award for 2022:
  Prestigious European prize to Bente Halvorsen
• Application date May 31st:
  Giant grant from the Norwegian Cancer Society
• Sign up for the first innovation hangout in Oslo Science Park 21 April:
  Tomorrow's treatment – advancing innovations from academia to industry in cancer and beyond

Mar 2022

• Publication from Centrosome & Cell Division Cycle project group on cover of Bio-protocol
• Selected cover image of BBA Reviews on Cancer for 2022
• Haematologica publication:
  Cancer patient at OUH received treatment guided by drug sensitivity testing of tumor cells

Feb 2022

• Biomarkers in prostate cancer:
  Multi-sample transcriptomics overcomes heterogeneity and reveals genes with prognostic biomarker potential
• Application deadline - April 29th 2022
  New call from National program for clinical therapy research in the specialist health service
• EMBO reports publication:
  Are doping tests in sports trustworthy?
• Excellent Researcher Award and Early Career Award 2022:
  Nominate an outstanding scientist at Oslo University Hospital
• Three new strategic research areas appointed by Oslo University Hospital

Dec 2021

• NORMENT researchers discover genes that shape human brain surface
• Researcher of the year 2021 at the Institute for Cancer Research:
  Kay Oliver Schink
• Employee of the year 2021, the Institute for Cancer Research:
  Idun Dale Rein
• IMPRESS-Norway and Illumina enter into cooperation

Nov 2021

• New vaccine therapy against multi-resistant tuberculosis bacteria is under development
• Dutch-Nordic Alliance for Precision Cancer Medicine launched
• Offers for OUH researchers involved in developing vaccines:
  Open Calls for TRANSVAC2 Trainings and Vaccine Development Services
• Dr Ragnar Mørk´s Prize for excellent cancer research 2021 to Anita Sveen
• Kay Oliver Schink identifies a new regulator of macropinocytosis, an important mechanism for nutrient acquisition by cancer cells
• Event Wednesday 24th November 2021 1:30 pm:
  Domore! and beyond - AI in CANCER DIAGNOSTICS
• Novel biomarker for Antibody Drug Conjugate
• New treatment for rare cancer pseudomyxoma peritonei

Oct 2021

• Transplant Immunology Decision Support System (TRIMMUS)
• Apollo article covering Ira Haraldsen's research:
  Early dementia revealed by artificial intelligence
• Science Signalling paper from Taskén group:
  Systems analysis of prostaglandin E2 signaling networks through four GPCRs on T cells

Sep 2021

• Nature Genetics publication:
  New causes for Alzheimer's discovered
• Lasse Pihlstrøm's research on dementia presented in Apollon
• Publication from The Norwegian Cancer Genomics Consortium in Genome Medicine
• Discovered gene patterns can predict prostate cancer treatment response

Aug 2021

• Ragnhild Lothe awarded the Excellent Researcher Award 2021 at the Oslo University Hospital
• New "super albumin" technology can improve the treatment of bleeding disorders

Jun 2021

• Jan Terje Andersen and Per Morten Sandset new board members of The Life Science Cluster
• Ceremony available via YouTube:
  Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2020

May 2021

• New study reports 64 risk genes for bipolar disorder

Apr 2021

• Centre for Advanced Cell and Gene therapy launched
• Annual Report from the Institute for Cancer Research for 2020
• Webinar, May 11, 2021:
  Health Research in Horizon Europe
• Pål Kristian Selbo receives NOK 3.75 million from Radforsk Investment Foundation
• Findings published in NEJM:
  Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
• Jan Terje Andersen interviewed for the FcRn-Targeted Therapies for Autoimmune Disorders Summit

Mar 2021

• PANCAIM: A European consortium to improve pancreatic cancer treatment with artificial intelligence optimizing, integrating genomics and medical imaging
• Fridtjof Nansen award 2021 for excellent research to Harald A. Stenmark

Feb 2021

• AI-Mind: an innovative solution that will revolutionize early detection of dementia
• Novel findings published in Annals of Neurology: 
  Genetic study highlights the importance of microglia in Parkinson’s disease
• New international project on the causes of epilepsy development after head injury in progress
• Project from Weyergangs project group admitted to SPARK Norway
• Awarded 9 million NOK to study autophagy in prostate cancer

Jan 2021

• Application deadline - 30. april 2021
  New call from National program for clinical therapy research in the specialist health service
• The new Scientific Advisory Board for the Institute for Cancer Research meets
• New Nature paper:
  Eating droplets piecemeal or in one big bite
• Inside the head of a researcher:
  Cancer is a genetic disease
• In Nature:
  The Olweus lab reports that translational mistakes in cancer can be targets of immunotherapy

Dec 2020

• The OMEMI trial achieves international publicity
• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2020
• The Syljuåsen Lab reveals mechanisms preventing replication stress
• Sandvig-group with an article about uptake of nanoparticles into tumors
• Publication in new flagship medical journal Med:
  The Malmberg Lab reports a systems-level immune profiling in patients with DLBCL
• IMPRESS NORWAY: Large national precision medicine study in cancer

Nov 2020

• Spanish independent young researcher position awarded to Caroline Nunes-Xavier
• How can researchers at UiO and OUS publish openly and free of charge?
• Olweus interviewed by Apollon about OUTSOURCE immunotherapy project
• Dr Ragnar Mørk´s Prize for excellent cancer research 2020 to Theo Theodossiou
• Cell biologists and biophysicists join forces to bend biological membranes

Oct 2020

• Oslo University Hospital and the Norwegian Institute for Public Health to co-lead international collaboration on clinical trials for Covid-19 and future pandemics
• ERA PerMed grant awarded to European consortium led by Sigrid S. Skånland
• A novel biomedical technology that enhances half-life and mucosal delivery
• The success story of the Norwegian SARS-CoV-2 study

Sep 2020

• The 2020 Oslo University Hospital Researcher Awards to Bretthauer, Hoffmann-Vold and Kristianslund
• PNAS publication:
  Allows for new treatment of covid-19 patients
• 9. National research conference in musculoskeletal health 19-20 Nov 2020
• The UiO's Innovation Prize for 2020 awarded to Bjarne Bogen
• The UiO’s Research Prize awarded to Ole Andreassen
• Industry development agreement for innovative eye syringe
• First in the world with unique immunotherapy

Aug 2020

• Substantial support from the Pink Ribbon campaign to cancer research
• Andersen appointed professor in biomedical innovation at UiO:
  Innovation motivated by patients
• Institute seminar August 26th:
  Infrastructure for precision medicine in cancer; bridging a gap between research and clinical practice?
• TP53 proficient colorectal cancer cells are sensitive to PARP inhibition

Jul 2020

• Bicycling the whole of Norway and gathering funds for the Norwegian Cancer Society

Jun 2020

• Uncontrolled membrane repair causes chromosome fragmentation
• npj Breast Cancer article from Sørlie's research group:
  Basal-like DCIS may not be a precursor to basal-like invasive breast cancer
• From national report on research and innovation:
  Anabolic steroids and effects on emotions
• From the annual national research report:
  Research project on circulating biomarkers presented
• Sandvig group publishes that changes in the membrane lipids diacylglycerol and phosphatidic acid alter intracellular transport
• Pedersen and Raiborg identify mechanism of how cancer cells grow protrusions that promote tissue invasion

May 2020

• Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2019
• Gunnveig Grødeland interviewed for Uniforum
• Video award to Aleksandra Dukic
• Antoni Wiedlocha funded by the EEA Poland-Norway grants

Apr 2020

• The cancer patient’s own drug sensitivity model
• Nature Communications publication:
  Claudin-low – truly an intrinsic breast cancer subtype?

Mar 2020

• Clinical trials and research projects at Oslo University Hospital related to patients with COVID-19 and SARS CoV-2 infection
• Measuring antibodies against viruses is simpler and less expensive than detecting the virus itself
• Ludvig M. Sollid and Knut E. A. Lundin interviewed about celiac disease research
• Norwegian SARS- CoV-2 study

Feb 2020

• Cancellation of seminar:
  Lectures March 17th cancelled
• Announcement:
  4th Oslo Epigenetic Symposium April 16th to 17th 2020
• Improved personalized treatment through "organ-on-a-chip" technology
• National expert group receives 15 million for pancreatic cancer research
• Olweus supported by the Novo Nordisk Foundation
• Lancet article on artificial intelligence and prediction of colorectal cancer outcome with Aftenposten front page coverage
• Unprecedented exploration generates most comprehensive map of cancer genomes charted to date
• The Norwegian Cancer Society grants 14.8 MNOK to a National Group of Expertise on Lung Cancer
• Horizon 2020 EU funding to the PainFACT-project and Bente Halvorsen
• Mouldy Sioud editor of new Methods in Molecular Biology book:
  Harnessing RNA and CRISPR interferences for cancer therapy
• The Norwegian Biochemical Society (NBS) – Oslo invites you all to a special evening Feb 6th:
  An inaugural talk given by Professor Harald Stenmark

Jan 2020

• Popular science feature article in Aftenposten Viten:
  Can statistics and mathematics save as many lives as new medicines?
• A basic study of the cell cycle by mass cytometry, with implications for exclusion of non-single cell events as ion cloud fusions and aggregates.
• Meeting in Oslo January 27-28, 2020:
  The Genetics and Genomics of Cancer
• National meeting about advanced molecular cancer diagnostics
• Article in Science from Kalager and Bretthauer:
  Improving cancer screening programs
• Tuula Nyman awarded millions for scientific infrastructure for proteomics research
• Excellent Researcher Award and Early Career Award 2020:
  Nominate an outstanding scientist at Oslo University Hospital
• Theodossiou interviewed for Smithsonian Magazine on how natural light may be used to kill cancer cells

Dec 2019

• Pierre Chymkowitch granted support from the FRIPRIO program
• Åslaug Helland principal investigator of large, randomized combination trial in mesothelioma
• Theodossis A. Theodossiou researcher of the year at the Institute for Cancer Research
• ERC Consolidator Grant of 20 million NOK awarded to Johanna Olweus
• New immune-related breast cancer subtypes described in Nature Communications
• How B cell receptor ligation and T cell help drives chronic pathological B cell expansion

Nov 2019

• Young researcher award to Peter Wold Eide at “Onkologisk Forum”
• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2019
• Findings published in Nature Immunology:
  A natural occurring lipid can dramatically affect the function of NKT-cells
• Ceremony Friday November 15th:
  Ragnar Mørk legacy prize 2019 to Karl-Johan Malmberg
• Vessela Kristensen appointed Head of Research at the Department of Medical Genetics.
• Vietri, Radulovic and Stenmark with Nature Review about ESCRT proteins in membrane dynamics
• Bridging the gap to proteomics with new high-parameter instruments at the Flow Cytometry Core Facility

Oct 2019

• Lectures and Cermony October 31st
  The Anders Jahre Award for Young Scientists 2019 to Lars Tjelta Westlye
• Epilepsy Research Group (ERGO) seminar, Kleivstua 17-18 October 2019
• Recently approved breast cancer test based on Norwegian research
• The Inven2 Idea Prize 2019 won by OUH scientists
• Updated and expanded text Nov 4th:
  Lung cancer research funded by national clinical research program KLINBEFORSK
• Report in Current Biology by Lie-Jensen and Haglund:
  Parallels between ALIX recruitment during cytokinetic abscission in flies and virus budding in human cells
• HIV research performed by Jan Terje Andersen's group presented in Aftenposten
• The Innovative science 2019 award-winning LUMIBLAST concept:
  Fighting brain cancer through photodynamic therapy, using light from within
• Oslo University Hospital contributions at ESMO 2019 presented by Dagens Medisin
• Holmenkollen Park Hotel September 18-20th 2019:
  18th Annual CHFR Symposium on Heart Research

Sep 2019

• Open seminar Oct. 9, 2019 11:30 AM–12:30 PM, Forskningsparken
  An Introduction to EATRIS, Europe’s Translational Research Infrastructure for Translational Medicine
• 2019 Innovation Radar Prize for Innovative Science to Lumiblast
• Brain aging in common brain disorders
• Center for Cardiological Innovation (CCI) partners granted a new EU-financed project
• Norwegian Inflammation Network (NORIN) Crystal Ball Seminar September 23rd:
  Future approaches to understand and treat inflammatory diseases
• H2020 funding for exploration of the secretory pathways to identify candidate biomarkers or therapeutic targets
• ERGO at EAN 2019 - Presentations of PhD projects
• ERGO at EAN 2019
• Comprehensive review article about the complexity of biomarkers in colorectal cancer published in Nature Reviews Clinical Oncology
• Could Light-Activated Drugs Turn Proton Therapy into a More Radical Treatment for Cancer?
• Personalized prediction of drug dose

Aug 2019

• The 2019 Oslo University Hospital Researcher Awards to Andreassen, Kalager and Sveen
• New insights into the molecular mechanism underlying a human developmental disorder published in Cell Reports
• Yan Zhen identifies mechanism of autophagosome closure

Jul 2019

• Jan Terje Andersen head of hiv research program receiving 19 mill NOK
• Announcement from Helse Sør-Øst:
  Call for applications for research-based innovation
• Announcement from Helse Sør-Øst:
  Call for applications for health research

Jun 2019

• Marte Sneeggen identifies new mechanism how a tumor suppressor prevents metastasis
• UiO:Life Science funds convergence environment on proton therapy research
• Perspective article in Nature Communications by Skotland and Sandvig:
  Importance of studying lipid species, not only lipid classes
• Three new strategic research areas appointed by Oslo University Hospital
• National meeting about advanced molecular cancer diagnostics
• Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2018
• Clinical studies - projects with many supporters

May 2019

• New research blog:
  Clinical Trials – more than new drugs
• Johanna Olweus elected member of the executive board of CIMT
• Tor Erik Rusten's research presented:
  Autophagy - Hope or Threat to Cancer Patients?
• Clinical Trials Day - May 20th 2019
  Clinical studies - the road to better treatment
• New genes linked to bipolar disorder
• Radforsk to invest NOK 4.5 million in cancer research

Apr 2019

• At OUH Rikshospitalet 8-10 May 2019:
  The 13th International Symposium on Medical Information and Communication Technology
• The first Norwegian CAR
• Successful kick-off for new collaboration between Institute for Cancer Research and Institut Curie

Mar 2019

• A revolutionary technique for faster and more accurate regional anesthesia
• Childhood trauma in patients with severe mental disorders linked to shorter telomeres

Feb 2019

• The Flatmark group heads new European initiative connecting researchers working with rare cancer pseudomyxoma peritonei
• Maria Torgersen and coworkers publish unexpected results about nanoparticle effects on cells
• Computer simulated cancer treatment presented in research magazine Apollon

Jan 2019

• Nature Communications publication:
  How Natural Killer Cells Remember their Education
• Funding from FRIPRO to five promising researchers from Oslo University Hospital
• Research at Oslo University Hospital basis for international drug development initiative between Norway and India
• Genetic overlap between bipolar disorder and intelligence
• Nature Biomedical Engineering publication:
  Study reveals how solid stress from brain tumors causes neuronal loss and neurologic dysfunction
• The Lancet article with statistical contribution from OUS:
  Avoiding unnecessary Caesarean sections

Dec 2018

• Nature Communications publication:
  Single-molecule experiments reveal how DNA repair enzymes look for damages using a combination of helical sliding and jumping
• Research funding from South-Eastern Norway Regional Health Authority for 2019
• New link between DNA damage signaling and the transcription machinery is identified by scientists from the Department of Radiation Biology
• Myeloma research funded by national clinical research program KLINBEFORSK
• Award ceremony December 7th
  Oslo University Hospital awards 6 excellent articles for the first half-year of 2018
• International collaborative project led by Harald Stenmark supported with millions

Nov 2018

• Kristin Bjordal "Researcher of the Month" for November 2018
• New and important findings from the ERGO group:
  Glial cells play an important role in epilepsy
• Ceremony Friday November 23rd:
  Ragnar Mørk legacy prize 2018 to Kaisa Haglund
• Molecular Oncology cover features work by the Russnes group

Oct 2018

• Helene Knævelsrud new member of The Young Academy of Norway
• ESMO Congress i Munich 19-23 Oct 2018
  Therese Sørlie interviewed for Dagens Medisin about current trends in cancer research
• Researchers at the Department of Immunology publish groundbreaking proteomics technology in Nature Methods.
• Guro E. Lind new leader of The Norwegian Association of Researchers (Forskerforbundet)
• EMBO J paper from Maja Radulovic:
  Repair of damaged lysosomes keeps cells alive
• The Anders Jahre Award for Young Scientists 2018 to Espen Melum
• Honorary Award to Ole Andreassen
• An article published in Cell by a research team from Oslo and Zürich reveals a new aspect of chromosome biology:
  To spread or not to spread?
• Skotheim group publishes important prostate cancer study in prestigious journal:
  High degree of genomic heterogeneity in multifocal primary prostate cancer
• The Malmberg lab partner in major cancer immunotherapy project

Sep 2018

• Paper from Weyergang´s project group published in Journal of Controlled Release
• How do cells keep their assembly lines in synchrony?
• Nature Communications publication selected for Editor's Highlight webpage:
  A study of the epigenetics of breast cancer provides clues to mechanisms behind subtypes of the disease

Aug 2018

• UiO Research Award ceremony Sept 3rd
  Harald Stenmark interviewed for Uniforum
• Research team from Oslo and Eindhoven discovers wound healing without a wound
  A mere drop of blood makes skin cells line up
• Molecular Cancer Therapeutics article from Namløs, Boye and Meza-Zepeda:
  ctDNA reveals tumour heterogeneity and burden in gastrointestinal stromal tumours
• Wednesday 22nd of August
  Celebration of Harald Stenmark’s ERC Advanced Grant
• Research on brain clearance function presented by national newspaper VG
• Cancer Research paper from Lyng's group highlighted in Nature Reviews Urology:
  Novel imaging method to assess prostate cancer aggressiveness
• ERC Starting Grant 2018 to Johannes Roksund Hov

Jul 2018

• Nature Communications paper from Wenzel and Raiborg:
  Timing of growth factor receptor downregulation
• The "Domore!" project presented by national newspaper VG
• Dag Berild "Researcher of the Month" for July 2018

Jun 2018

• Postdoctor Andreas M. Hoff is shared first-author
  New publication in Cell on structural genome alterations driving castration-resistant prostate cancer
• The University of Oslo Research Award 2018 til Harald Stenmark
• Announcement of research funding from South-East Norway regional health authority for 2019
• Therese Seierstad "Researcher of the Month" for June 2018
• EMBO Journal article from Malerød and Haglund: Orienting the spindle
• The 2018 Oslo University Hospital Research Awards to Klungland, Haugaa and Westlye
• Project headed by Ilangko Balasingham placed on the Horizon 2020 Innovation Radar
• Questionable use of beta blockers in heart attack treatment:
  BETAMI trial funded by Klinbeforsk

May 2018

• Support from Horizon 2020 to 16 projects headed by Oslo University Hospital
• Paper from Selbo’s project group featured on the cover of Photochemical & Photobiological Sciences
• Award ceremony May 25th
  Oslo University Hospital awards 6 excellent articles for the second half-year of 2017
• Gut bacteria flora linked to chronic heart failure
• Theodossiou and Berg presented in national media after receiving prestigious EU grant

Apr 2018

• Oslo Myeloma Center in the media
• OUS research blog article:
  Treating rare bleeding disease with cancer medicine
• Espen Melum "Researcher of the Month"
• OUH research seminar, Monday, April 16th, 2018, at 14:30 – 16:00
  Precision medicine in complex diseases
• European Research Council Advanced Grant to Stenmark for the second time
• Mini symposium Cancer Genomics, April 17th, 10am-4pm
  On the occasion of King Olav V's award to Professor Vessela N. Kristensen
• Cancer study led by OUH scientists presented by major national newspaper VG

Mar 2018

• Novel subtype-specific prognostic associations of KRAS and BRAF mutations revealed in colorectal cancer
• Prestigious neurological award to David Russell
• Jon Amund Kyte "Researcher of the Month"
• International Women's day, March 8th 2018:
  The Challenges women face in pursuing a career in STEM (science/ technology/ engineering/ mathematics)
• Updated:
  King Olav V´s Cancer Research Prize for 2018 to Vessela Kristensen
• OUH research seminar, Monday, March 5th, 2018, at 14:30 – 16:00
  Tissue engineering and regenerative medicine

Feb 2018

• Nature Communications publication:
  A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
• Kyrre Emblem among the three research talents honoured by the Norwegian Research Council
• Ole Jacob Elle appointed "Innovator of the Month" by "Helse Sør-Øst"
• Substantial grant from HELSEVEL to Jon Michael Gran
• Leiv Arne Rosseland "Researcher of the Month" for January 2018
• Interdepartmental collaboration cuts drug costs on expensive antibodies for treating eye diseases
• Prestigious grant to Tor Erik Rusten

Jan 2018

• OUH research seminar, Monday, February 5th, 2018, at 14:30 – 16:00
  New developments in gynecologic oncology
• Karl-Johan Malmberg interviewed by NRK on the potential of killer cell research in cancer treatment
• Therese Sørlie appointed "Scientist of the Month" by "Helse Sør-Øst"
• Press release
  Tillotts Pharma AG signs license agreement on antibody technology developed by OUS and UiO scientists
• Rusten group research project on cell organisation and tumor growth highlighted by the Norwegian Cancer Society
• Nominating outstanding scientists, closing date March 1st:
  Excellent Researcher Award and Early Career Award 2018
• OUH research seminar, Monday, January 15th, 2018, at 14:30 – 16:00
  Genetics of cardiovascular diseases
• Cell therapy research presented in national newspaper VG
• Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer

Dec 2017

• The discovery of TIGIT as a potential new target for immune checkpoint blockade is published in Clinical Cancer Research.
• Scientists from the Research Institute of Internal Medicine receive funding from ERA-Net
• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2017
• Per Steinar Halvorsen appointed "Innovator of the Month" by Helse Sør-Øst

Nov 2017

• OUH research seminar, Monday, December 4th 14:30
  The challenges of discovering new antibiotics
• Press release – 29 Nov 2017
  The Laboratory of Adaptive Immunity and Homeostasis enters a strategic research collaboration with a leading pharmaceutical company
• Alicia Llorente participates in an ERA-NET funded project
• Young Investigator Prize to Anita Sveen during annual "Onkologisk Forum" meeting Nov 2017
• Michael Bretthauer appointed "Scientist of the Month" by "Helse Sør-Øst"
• Paper on novel pathway selected for inclusion in the ‘In This Issue’ section of Journal of Cell Science
• Jan Terje Andersen receives a grant of 8.5 million NOK from NANO2021
• Professor Kjetil Taskén is presented as new director of the Department of Cancer Research at the Cancer Clinic, Oslo University Hospital
• Nature Communications publication:
  Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
• Maria Torgersen receives a grant of 8.5 million NOK from NANO2021
• Nature Communications article from OCBE:
  Inequality in genetic cancer risk: Bad genes or bad luck?

Oct 2017

• Update: Nature Cell Biology paper attracts interest:
  Rusten group uncovers new regulatory mechanism of the Peutz-Jeghers cancer syndrome kinase, LKB1
• CNN coverage:
  Major study of genetics of breast cancer provides clues to mechanisms behind the disease
• Albumedix has signed research agreement with OUS and UiO on CIR research
• CCB researchers uncover novel mechanism of cellular metabolic control
• Breast cancer research highlighted by the Norwegian Cancer Society:
  New additional treatment for breast cancer patients
• OUH research seminar, Monday, October 9th 14:30
  Individualized cancer treatment
• Induced pluripotent stem cell research featured on Norwegian national news broadcast

Sep 2017

• Tor Inge Tønnessen "Researcher of the Month" for September
• Collaboration to identify novel biomarkers that can predict whether a patient will respond positively to pembrolizumab
• Sept 29th - Information day about EMBL, EMBO and HSPF:
  Scientific opportunities in Europe
• Jahre lecture Thursday September 14th
• Scandic Holmenkollen Park, December 4-6, 2017:
  The Norwegian Cancer symposium 2017 on Precision Medicine

Aug 2017

• Anne-Lise Børresen-Dale appointed Commander of the Royal Norwegian St. Olavs Order
• ERC Starting Grant 2017 to Kyrre Eeg Emblem
• Tone Rustøen "Researcher of the Month" for July
• Håvard Danielsen appointed "Scientist of the Month" by "Helse Sør-Øst" for June 2017

Jul 2017

• OUH scientists involved in sequencing study of osteosarcoma that has identified mutations in IGF signalling genes

Jun 2017

• Øyvind S. Bruland appointed "Innovator of the Month" by Helse Sør-Øst
• Lars Tjelta Westlye appointed "Scientist of the Month" by "Helse Sør-Øst" for May 2017
• Call for applications 2018
  Announcement of research funding from South-East Norway regional health authority for 2018
• Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2016
• Clinically important genetic heterogeneity in colorectal cancers with microsatellite instability
• Per O. Seglen awarded King Olav V's cancer research prize for 2017

May 2017

• New mechanism for rare skin disorder discovered
• Less expensive medicine results in treatment for more patients
  Norwegian research with international impact
• The 2017 Excellent Research Awards to Kirsten Sandvig, Johannes Espolin Roksund Hov and Tor Paaske Utheim
• OUH research seminar, Monday, May 8th 14:30 - 16:00
  Organ donation for abdominal and thoracic organs
• Program Info - workshops held May 8-9th:
  Placing my research in an H2020 project

Apr 2017

• New insight into late effects after cancer treatment presented by the Norwegian Cancer Society
• OUH research seminar, Tuesday, April 25th 10:00 - 15:45
  Immunotherapy for Cancer
• Study on replication fork stability from Skarstad group published in Nucleic Acids Research

Mar 2017

• OUH research seminar, Monday, April 3rd 14:30
  Innovation to Finance Research
• NORMENT researchers contribute to PLOS Medicine article on genetic assessment of age-associated Alzheimer's disease risk
• The AACR-WICR Friend Lectureship presented to Anne-Lise Børresen-Dale
• CanCell - a new Centre of Excellence - will reprogram cancer cells
• New group leader at the Institute for Cancer Research:
  Jørgen Wesche appointed group leader for the Mesenchymal Cancer Biology Group at the Department of Tumor Biology
• King Olav V´s Cancer Research Prize to Per O. Seglen
  Prestigious research prize from the Norwegian Cancer Society to pioneer in autophagy research
• OUH research seminar, Monday, March 6th 14:30
  Health after transplantation

Feb 2017

• NORMENT study published in Nature Neuroscience:
  Early signs of mental illness in the developing brain
• Breakfast lecture in Oslo Wednesday March 1st:
  Arne Klungland talks about embryo research
• Invitation to seminar March 2nd 12:00
  Thon Awards seminars 2017
• Critical article on doping and drug testing published in EMBO reports
• OUH research seminar, Monday, February 6th 14:30
  Early phase drug development: From idea to concept
• "Science" article from Johanna Olweus's group highlighted by editorial in New England Journal of Medicine

Jan 2017

• Oslo Kongressenter, February 09-10 2017
  6th National Conference on Stroke
• Theis Tønnessen appointed "Scientist of the Month" by "Helse Sør-Øst" for January 2017
• OUH research seminar, Thursday, January 26th
  Sepsis: New definitions and future research
• Announcement: Nominating outstanding scientists, closing date March 1st:
  Excellent Researcher Award and Early Career Award 2017
• OUH research seminar, Monday, January 16th
  Antimicrobial resistance - how bad is the situation in the world of virus, fungus and mycoplasma?
• Updated: honoured with "Preview" article in Developmental Cell
  Findings from Rusten group published in Nature on microenvironmental autophagy draw nationwide attention
• Commentary article from Arne Klungland in Nature Methods on epitranscriptome analysis

Dec 2016

• Research funding from South-Eastern Norway Regional Health Authority for 2017
• Educating future cancer researchers from Ullern high school
• Novel cancer immunotherapy published in Cancer Research, with cover illustration

Nov 2016

• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2016
• Monday, November 21st, 2016, at 14:30 – 16:10
  Oslo University Hospital research seminar: Exercise and Brain Energy
• Thursday November 17th at 10:00-15:00
  Oslo University Hospital research seminar: The World of Immunology

Oct 2016

• Results of Open Call 2016:
  Oslo University Hospital researchers receive 77.3 mill NOK from the Norwegian Cancer Society
• Human lung macrophages are self-maintained for several years
• Gathering Friday October 28th 10-12 at UiO:
  Announcement of research funding from the Norwegian Cancer Society
• Dag Berild awarded the "Akademikerprisen" for his work on antibiotic resistance
• Thursday 13 October 2016 at 10.15 AM
  50 years anniversary Institute for Surgical Research
• Making therapeutic antibodies from scratch
• Lina Prasmickaite's work presented in popularised form
• Oslo University Hospital research seminar Monday October 10th
  Medical imaging in cardiac research

Sep 2016

• Focus on personalized medicine and the MetAction study
• Paper from Dahl/Klungland published in the Sep 22nd issue of Nature
  Histone marks regulate maternal-to-zygotic transition
• National kick-off, Tuesday September 13th
  Turning the tide of antimicrobial resistance
• Marina Vietri interviewed for major Italian research web portal

Aug 2016

• OUH researchers publish groundbreaking computer tools for cell biology research in Nature Methods
• POLE proofreading domain mutations identify a subset of immunogenic colorectal cancers with excellent prognosis
• Clinical Cancer Research highlights biomarker paper from Lyng’s group
• The Norwegian Cancer Genomics Consortium participates in international study of gene variants predisposing for cancer development.

Jun 2016

• Call for applications 2017
  Announcement of research funding from South-East Norway regional health authority for 2017
• H.M. the King's Gold Medal to Marina Vietri
• Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2015
• South-Eastern Norway Regional Health Authority brings attention to innovation:
  Atle Bjørnerud "Innovator of the Month"
• Symposium at OUS, Rikshospitalet, 17. June 2016 13:00-15:30
  Tomas Lindahl, Nobel Prize laureate 2015

May 2016

• Oslo University Hospital honouring outstanding scientific work:
  The 2016 Excellent Research Awards to Pål Aukrust, Therese Seierstad and Espen Melum
• Strønen and Olweus publish article in Science on the use of donor immunity to target cancer
• Håvard Danielsen and Erik Fosse receive Lighthouse project grants from the Norwegian Research Council
• OUS scientists partners in project funded by HORIZON 2020 FAST TRACK TO INNOVATION
  "Intelligent needle tracking using ultrasound imaging for improved minimally invasive interventions" supported by EU
• Oslo University Hospital research seminar Monday May 9th
  Discovery of biologically active small molecular compounds
• OUS scientists co-author Nature article:
  Mapping somatic mutations in breast cancer whole genomes

Apr 2016

• Same, but different? Genetic analysis of five immune mediated diseases reveals molecular taxonomy of chronic inflammation
• Information meeting, Radiumhospitalet, Friday April 22nd
  New guidelines for "Helse Sør-Øst" and "Kreftforeningen" applications
• Article published in Science Translational Medicine showing that cyclodextrin may reduce atherosclerosis attracts worldwide attention
• The Fridtjof Nansen Award for Young Scientists for 2016 to Kyrre Eeg Emblem
• Institute seminar April 6th
  Ståle Nygård – Dept. of Core Facilities

Mar 2016

• Theodossiou and Berg funded by the Future and Emerging Technology (FET) program
• King Olav V's cancer research prize for 2016 to Kjetil Taskén
• The Norwegian Inflammation Network seminar Wednesday March 16th
  Morgendagens medisin
• Oslo University Hospital research seminar Monday March 14th
  Microbiome
• Day of Immunology Conference 2016 April 29
  Immunotherapy for Cancer
• Liliane Christ identifies mechanism for regulation of daughter cell separation

Feb 2016

• NoPSC study of PSC gut microbiota published in Gut
• Invitation to seminar March 3rd 12:00
  Olav Thon Foundation's International Prize and Research Awardees 2016
• Norsk Hydro's Fond guest lecture March 10th
  Stephen H. Friend
• Ragnhild A. Lothe and Michael Bretthauer substantially supported by FRIPRO

Jan 2016

• Camilla Raiborg's work presented in popularised form on forskning.no:
  Filming live cancer cells
• Heart study results recently published in Lancet attract attention:
  Elderly patients benefit from an early invasive strategy
• Lorenz et al. published an extensive study investigating the genomic chaos in osteosarcoma
• Symposium, Oslo, May 18-20, 2016
  Personalized Cancer Care
• Åslaug Helland's research on lung cancer presented by the Norwegian Cancer Society
• Innovation projects funded by the Norwegian Cancer Society and Research Council
• Oslo University Hospital research seminar January 11th
  Medical imaging in cancer biology and personalized therapy
• Sandvig received INNO INDIGO grant for work with biodegradable nanoparticles

Dec 2015

• Work from Bjørås' group published in "Cell Report"
• Research funding from South-Eastern Norway Regional Health Authority for 2016
• AACR Recognizes Dr. Anne-Lise Børresen-Dale With 2015 Distinguished Lectureship in Breast Cancer Research
• Erik Boye - an internationally renowned scientist retires
• Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2015
• New PhD Andreas Hoff publishes testis cancer fusion genes in Cancer Research
• Institute Seminar Wednesday 9th of December at 12:00
  Asta Juzeniene - Dept. of Radiation Biology

Nov 2015

• Findings regarding a novel non-genomic tamoxifen cytotoxic action published in ACS Chemical Biology
• Tor Espen Thorvaldsen with cover story in Molecular Cancer Research
• Oslo University Hospital researchers receive 92 mill NOK from the Norwegian Cancer Society
• Ceremony Friday November 20th
  Ragnar Mørk legacy prize 2015 to Guro E. Lind
• The first-in-man Phase I clinical trial of the EpCAM-targeting immunotoxin MOC31PE
• Research on sonoactivatable nanoparticles funded by EuroNanoMed II ERA-NET program
• Research on nanoparticle radiosensitizers funded by Euronanomed II ERA-NET program
• PCI research funded by Euronanomed II ERA-NET program
• Institute Seminar Wednesday 4th of November at 12:00
  Jørgen Wesche – Dept. of Molecular Cell Biology

Oct 2015

• New gold-standard for miRNA annotations published in Annual Reviews of Genetics
• Oslo University Hospital research seminar October 19th
  The Wonder of Stem Cells in Eye and Oral Regeneration

Sep 2015

• Presenting the Young Academy of Norway
• Møbius 2015:
  Prestigious award from the Research Council of Norway to Harald A. Stenmark
• Review article from Sveen and co-workers on alternative splicing published in Oncogene
• The Anders Jahre Senior Medical Prize to Ludvig Sollid
• The UiO Innovation Prize:
  Award winner Erik Fosse presented in Uniforum
• Two studies of PARP inhibition in malignant lymphocytes reveal differential phenotypical responses, DNA damage induction and repair during the cell cycle
• Recognition of outstanding scientific work:
  Kaisa Haglund receives the Jahre prize for young medical researchers

Aug 2015

• Oslo Cancer Cluster Innovation Park officially opened
• New English version of "The Research Handbook- from idea to publication" is available
• Chronicle on personalised cancer medicine in Aftenposten
• Training course August 25:
  Preparing for the upcoming health calls for Horizon 2020
• Novel method reveals new knowledge about G1-phase
• H.M. The Kings Gold Medal to Sigrid Bratlie Thoresen

Jul 2015

• Llorente and coworkers report promising prostate cancer biomarkers in urinary exosomes

Jun 2015

• Microscopy infrastructure funded by the Norwegian Research Council
• Innovation prize to Erik Fosse
• Cover article on personalized cancer medicine and big data in META
• Paper from OUS/CCB researchers dedicated commentary articles in both Nature and Science
• OUS research blog June 16th:
  What is the cost of a cancer patient's life?
• Call for applications 2016
  Annuncement of research funding from South-East Norway regional health authority for 2016
• The Department of Pathology receives funding for melanoma research through Horizon 2020 project.
• Findings from the Skarstad group published in PLOS Genetics
• OUS research blog about endocytosis:
  A cancer cell on the move
• William Louch appointed "Scientist of the Month" by "Helse Sør-Øst" for May 2015
• Article about work in the Stenmark group on www.nrk.no:
  The long road to success
• Nature article from Marina Vietri:
  Sealing holes in the nuclear envelope as a mechanism to protect the genome
• Review article in J Mol Cell Biol:
  Non-Homologous functions of the AlkB Homologs – an update of the present knowledge

May 2015

• WiBEC (Wireless In-Body Environment Communications) selected for funding by EU
  New EU H2020- MARIE Sklodowska-CURIE ACTIONS project coordinated by The Intervention Centre
• OUS research blog:
  Improved methods for the treatment of metabolic diseases affecting children's nervous system
• Public health improvement:
  Many OUS teams in the Holmenkollstafetten 2015
• Åsmund Eikenes publishes careers column in Nature

Apr 2015

• Oslo University Hospital honouring excellent research
• OUS research blog from Anja Nilsen:
  More precise cancer treatment by use of RNA biomarkers
• Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2014
• Article from Jorrit Enserink's group in "Genome research":
  Sumoylation of Rap1 mediates the recruitment of TFIID to promote transcription of ribosomal protein genes
• Fridtjof Nansen awards for excellent research to Anne-Lise Børresen-Dale and Jan Terje Andersen

Mar 2015

• The Losby conference on personalized cancer treatment
• Heidi Lyng appointed "Innovator of the Month" by "Helse Sør-Øst" for March 2015
• Nature article from Camilla Raiborg: Formation of cellular protrusions
• Journalists from Aftenposten following sarcoma team for 9 months:
  Sarcoma research presented in feature article in A-magasinet
• Thursday the 26th of March at 14:15 hrs:
  CCB Minisymposium on Centrosome and Cilia Biology
• Excellent OUS research presented by the Norwegian Cancer Society:
  New method for treatment of lung cancer
• EurocanPlatform workshop May 18-19th
  Circulating Biomarkers in Cancer
• OUS research blog by Ole M. Sejersted:
  Why research at hospitals should be encouraged
• Article from Kirsten Skarstad's group published in Nucleic Acids Research
• Kari Kværner blogs about research based innovation

Feb 2015

• Research on cancer vaccines against follicular lymphoma presented by the Norwegian Cancer Society
• Kristin Bjordal blogs about clinical research participation
• Recent article in Oncogene from Kristian Berg's PCI research group
• Novel DNA methylation biomarkers provide accurate detection of bile duct cancer
• Article in PLOS Genetics:
  Molecular control of abscission in stem cells in vivo
• Jens Petter Berg blogs about the values of basic research
• Solomon Yimer and Tone Tønjum involved in organising successful tuberculosis meeting in Ethiopia
• Rolf Skotheim interview in Apollon:
  Supercomputing reveals the genetic code of cancer

Jan 2015

• Two new research dissemination contributions from OUH/CCB scientists
• Leiv Arne Rosseland blogs about palliative care during childbirth
• Nanoparticle review by Iversen, Skotland and Sandvig among the most cited articles in Nano Today
• Theis Tønnesen blogs about research dissemination
• Announcement:
  Resources to PDT/PCI related research, 2015

Dec 2014

• Research funding from South-Eastern Norway Regional Health Authority for 2015
• Section for Cellular Therapy granted support from BIOTEK2021 and FORNY2020
• Institute seminar 19th of December. NB: 10-11 a.m.
  Gunnar Sæter
• Per Morten Sandset blogs about patient involvement
• Meza-Zepeda and Myklebost co-author recent Cancer Cell publication on the architecture and evolution of cancer neochromosomes
• Institute seminar 10th of December
  Arne Yndestad
• Stein Kvaløy blogs about cancer treatment through proton therapy

Nov 2014

• OUS research blog:
  Åsmund Husabø Eikenes blogs about understanding cell division through the study of fly spermatogenesis
• Oslo Kongressenter, February 12-13 2915
  5th National Conference on Stroke
• New genotyping service at Oslo University Hospital
• Oslo University Hospital has award 6 excellent articles for the first half-year of 2014
• Ceremony Friday November 21st
  Ragnar Mørk legacy prize 2014 to Arne Kolstad
• New book on RNA Interference edited by Mouldy Sioud recently published
• OUS research blog, November
  Why are we more allergic than before?
• “Centrosome and Cilia biology”-project headed by Sebastian Patzke highlighted by "Helse Sør-Øst"
• Benedicte A. Lie appointed "Scientist of the Month" by "Helse Sør-Øst" for October 2014
• Prostate cancer research presented by the Norwegian Cancer Society

Oct 2014

• 42 scientists from Oslo University Hospital granted 69.2 mill NOK from the Norwegian Cancer Society
• The Inven2 Idea Prize 2014 distributed
• Vessela N. Kristensen's research group presented by the Norwegian Cancer Society
• Important findings from Department of Genetics published in Genome Biology and highlighted in Biome magazine
• Research blog launched at Oslo University Hospital

Sep 2014

• Official opening of the KG Jebsen Colorectal Cancer Research Centre
• Two researchers from Oslo University Hospital among the world's most influential
• Oslo University Hospital awarding excellent research
• OUH researchers first and last authors on New England Journal of Medicine article

Aug 2014

• UiO's Innovations Prize 2014 to Øyvind S. Bruland
• Article from Hovig group published in Nucleic Acids Research
• OUH study suggesting link between maternal age and emergency delivery attracts attention
• Erik Fosse appointed "Scientist of the Month" by "Helse Sør-Øst" for July 2014
• Myklebost and Børresen-Dale co-authors on recent Science article on mobile DNA in cancer

Jul 2014

• OUH-paper featured on the 2012 AACR most-cited list
• Glioma treatment research project headed by Einar Vik-Mo and Iver Langmoen attracts attention
• Karin Cecilie Lødrup Carlsen appointed "Scientist of the Month" by "Helse Sør-Øst" for June 2014
• Department of Cancer Prevention held a public cancer research event for the Røst community

Jun 2014

• Helmholtz International Fellow Award to Anne-Lise Børresen-Dale
• Announcement of research funding from South-East Norway regional health authority for 2015
• Norwegian Cancer Symposium 2014 June 10-12, 2014
  Harnessing innate and adaptive immunity in cancer therapy
• King Olav V's cancer research prize for 2014 to Harald A. Stenmark
• Jens Petter Berg appointed "Scientist of the Month" by "Helse Sør-Øst" for May 2014

May 2014

• Super Resolution Microscopy Core Facility Opens at OUS
• Nature Cell Biology article from Sigrid B. Thoresen:
  ANCHR prevents aneuploidy
• Tuesday May 27th at 15 PM
  Kick-­Off: Norwegian Inflammation Network
• Kristian Berg elected as member of the Norwegian Academy of Science and Letters
• Kristensen and Børresen-Dale co-author article published in Nature Review Cancer
• Excellent papers published during the last half-year of 2013:
  Six research groups from OUS awarded for publishing excellent articles

Apr 2014

• Hanne Flinstad Harbo appointed "Scientist of the Month" by "Helse Sør-Øst" for March 2014
• Nansen prize for excellent research to Kirsten Sandvig
• Oslo Epigenetics Symposium 9. - 11. April 2014
• Successful cancer genomics conference at Losby followed up by national media
• Guest lecturer Wednesday April 2nd
  Dr. Paul S. Meltzer

Mar 2014

• Information about EU program supporting career development:
  Web TV broadcast of MSCA presentation
• Article from Kristian Berg's group accepted for publication in "Journal of Controlled Release"
• Ola Myklebost interviewed on national radio (NRK) on personalized cancer therapy

Feb 2014

• Karl-Johan Malmberg appointed "Scientist of the Month" by "Helse Sør-Øst" for February 2014
• Anette Weyergang first author on paper published in "Journal of Controlled Release"
• Helene Hartvedt Grytli first author on article printed in European Urology and mentioned in The Oncology Report

Jan 2014

• Mette Sprauten first author on publication in Journal of Clinical Oncology on longitudinal hormones in Testicular Cancer Survivors
• Guro Elisabeth Lind appointed "Scientist of the Month" by "Helse Sør-Øst" for January 2014
• Announcement:
  Resources to PDT/PCI related research, 2014
• Institute seminar January 15th - now available via Web TV
  EUs new research program – Horizon 2020
• Åsmund Eikenes awarded "Hjernekraftprisen 2013"
• Research funding from South-Eastern Norway Regional Health Authority for 2014
• Prestigious career grant for research on deciphering the functional effect of GWAS data

Mar 2013

• Annual reminder for OUS research personell:
  Information concerning NIFU's procedure in obtaining personal data for national FoU statistics